See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2021_Cymabay_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001042074, Cymabay Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 151,585,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,761,000 |
| 3 | remainder_Assets | 479,000 |
| 4 | LiabilitiesCurrent | 9,857,000 |
| 5 | LiabilitiesNoncurrent | 1,262,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,112,058 |
| 9 | ResearchAndDevelopmentExpense | 28,080,221 |
| 10 | remainder_Expenses | 5,069,370 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,616,234 |
| 13 | remainder_ComprehensiveNetIncome | 137,031 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 153,825,000 |
| 1 | Liabilities | 11,119,000 |
| 2 | Expenses | 50,261,649 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 142,706,000 |
| 5 | NetIncome | -45,645,415 |
| 6 | ComprehensiveNetIncome | -45,576,900 |
| 7 | BaseVar | 109,979,457 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.22 |
| 9 | EconomicCapitalRatio | 3.84 |
Edgar->Model Mapping
Feature Distribution
Change over Time
